Search

TAFA-93

TAFA93 is a novel prodrug of the mTOR inhibitor rapamycin which has successfully completed Phase 1 clinical development. mTOR inhibitors are currently used in the prevention of organ rejection in transplantation, the treatment of autoimm...

Sulfametrole

Aceprometazine

Although not widely prescribed, it is used in combination with meprobamate for the treatment of sleep disorders in France under the trade name Mepronizine.

ZYC300

It is designed as a vaccine, intended to increase immune system sensitivity to CYP1B1, an enzyme highly prevalent in tumor cells.

AM336

It was investigated as a potential treatment for various pain conditions.

(1R)-1-(2-thienylacetylamino)-1-phenylmethylboronic acid

These are aromatic compounds containing at least one benzene ring. This medication targets the protein beta-lactamase.

D-threo-neopterin

(From Stedman, 26th ed) Neopterin also serves as a precursor in the biosynthesis of biopterin.

Lexacalcitol

It is known to target the vitamin D3 receptor.

CK0802

[L16358] On the surface of these T-Reg cells, T-cell lung homing markers are expressed. … CK0802 is an off-the-shelf product composed of allogeneic umbilical cord blood derived regulatory T-cells (T-Reg cells), which can be used intravenously and without HLA matching.

GLB-001

GLB-001 is a orally bioavailable molecular glue degrader targeting casein kinase 1 alpha (CK1a).